The growing emphasis on value-based payment in health care suggests that the days of the traditional fee-for-service payment model, at least as the sole method of payment, are likely coming to an end. The Emerging Trends Symposium “The Challenge of Providing Value-Based Care for the Patient With Cirrhosis” on Monday morning will feature a panel of experts who will discuss alternative payment models and the effect that the evolving payment landscape will have on the practice of hepatology.
“It is becoming increasingly clear that the current model of fee-for-service is going to be at least partly replaced by other models of payment that have value integral to them,” said Hashem B. El-Serag, MD, MPH, who will co-chair the symposium alongside Hugo E. Vargas, MD, FAASLD.
“Some of the emerging value-based payment models have been stipulated by MACRA, which was released in 2015, and include bundled care and an increasing use of quality metrics, such as patient satisfaction,” Dr. El-Serag said. “Therefore, our specialty needs to prepare itself with the theoretical background of these models and with applied examples from our discipline, as well as from other disciplines, where these alternative methods of payment have worked.”
Among the scheduled presentations, John I. Allen, MD, will lay the groundwork for the symposium with a review of the existing and emerging alternative payment models and the transition from fee-for-services to providing value-based payment in hepatology. He will be followed by Michael M. Abecassis, MD, FAASLD, who will discuss an existing model of bundled payment that has been implemented successfully in liver transplantation.
“Dr. Abecassis is a liver transplant surgeon and an expert in the bundled payment model,” Dr. El-Serag said. “He will describe the lessons that can be learned from the transplant experience and the principles that can be extrapolated to other services.”
In the final presentation, Brett E. Fortune, MD, will review the current data on the impact of the chronic disease management model in liver disease and how the model has been successfully applied to the care of patients with chronic liver disease at the Yale New Haven Hospital in Connecticut.
The symposium will conclude with a panel discussion that will include multiple case scenarios that will educate attendees on how to prepare and adapt their practices to ensure the betterment of care to patients and the survival of the specialty as a competitor in the field.
“Some of these changes are here right now and more are on the horizon,” Dr. El-Serag said. “Clinicians need to learn about the examples that work and set their practices in a shape where they will be able to deliver value-based care. That is the essential step before payers consider paying differently for our services.”
Emerging Trends Symposium
10:30 am – Noon Monday
CC: Room 302/304